Seco (IOT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Net sales for H1 2024 declined to €95.3 million, down about 15% year-over-year, mainly due to customer destocking and weak demand across geographies and sectors.
Clea software business grew 17% year-over-year to €12.6 million, now contributing over 13% of total revenue and supporting improved profitability and margin expansion.
Gross profit margin improved by over 300 basis points to 52.7% compared to the same period last year, driven by higher software mix and lower component costs.
Adjusted EBITDA declined 40% year-over-year to €15.8 million (16.6% of sales), impacted by higher OpEx and unfavorable production mix.
Management remains focused on long-term profitable growth, innovation, and a strong rebound in 2025, targeting a return to double-digit organic growth and historical profitability levels.
Financial highlights
Net sales for H1 2024 were €95.3 million, down from €111.9 million in H1 2023, mainly due to high interest rates, reduced demand, and destocking trends.
Clea software revenue reached €12.6 million, 13% of total sales, up 17% year-over-year.
Gross margin at 52.7%, up over 300 bps year-over-year, driven by Clea and favorable component costs.
Adjusted EBITDA margin was 16.6%, down from 23.7% in H1 2023.
Adjusted net income was €3.9 million (4.1% of sales), down 69% year-over-year.
Outlook and guidance
Full-year 2024 revenues expected to exceed €180 million, with gross margin above 50%.
2025 guidance targets 15%+ organic top-line growth and a return to historical profitability, supported by new customer wins and normalization of demand.
Second half of 2024 revenues expected to be broadly in line with the first half, with gradual recovery in order intake.
CapEx plans have been reduced, with extraordinary investments halted.
OPEX to remain under control, with no short-term adjustments anticipated.
Latest events from Seco
- Q2 2026 sales beat guidance, gross margin rose, and Q3 is set for record revenue on strong AI demand.IOT
Q2 2026 TU15 Jul 2026 - Sales up 5%, margin at 53.8%, EBITDA up 50.8%, and €200M+ revenue guidance reaffirmed.IOT
Q3 20259 Jul 2026 - H1 2025 sales up 3.2%, gross margin 53.4%, EBITDA margin 20.5%, FY25 revenue to exceed €200m.IOT
Q2 20258 Jul 2026 - Sales fell 12.5–13%, but margins held firm and 2025 recovery is expected.IOT
Q4 20248 Jul 2026 - Net sales dropped 14% but gross margin and Clea software rose; partnerships fuel future growth.IOT
Q3 202417 Jun 2026 - Q1 2025 sales flat YoY, margins strong, Clea recurring revenue up, and order pipeline robust.IOT
Q1 202517 Jun 2026 - Net sales up 2.91% to €48.5m, Clea recurring revenue up 20%, and strong Q2 outlook.IOT
Q1 202613 May 2026 - FY25 net sales up 8% YoY, margins and cash flow improved, record backlog for 2026.IOT
Q4 202523 Mar 2026